Literature DB >> 30430955

Model systems for investigating disease processes in neurocysticercosis.

Anja de Lange1, Siddhartha Mahanty2, Joseph V Raimondo1.   

Abstract

Neurocysticercosis (NCC) occurs following brain infection by larvae of the cestode Taenia solium. It is the leading cause of preventable epilepsy worldwide and therefore constitutes a critical health challenge with significant global relevance. Despite this, much is still unknown about many key pathogenic aspects of the disease, including how cerebral infection with T. solium results in the development of seizures. Over the past century, valuable mechanistic insights have been generated using both clinical studies and animal models. In this review, we critically assess model systems for investigating disease processes in NCC. We explore the respective strengths and weaknesses of each model and summarize how they have contributed to current knowledge of the disease. We call for the continued development of animal models of NCC, with a focus on novel strategies for understanding this debilitating but often neglected disorder.

Entities:  

Keywords:  Animal models; Mesocestoides corti; Taenia crassiceps; Taenia solium; cestode; epilepsy; neurocysticercosis

Mesh:

Year:  2018        PMID: 30430955     DOI: 10.1017/S0031182018001932

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Taenia larvae possess distinct acetylcholinesterase profiles with implications for host cholinergic signalling.

Authors:  Anja de Lange; Ulrich Fabien Prodjinotho; Hayley Tomes; Jana Hagen; Brittany-Amber Jacobs; Katherine Smith; William Horsnell; Chummy Sikasunge; Dorit Hockman; Murray E Selkirk; Clarissa Prazeres da Costa; Joseph Valentino Raimondo
Journal:  PLoS Negl Trop Dis       Date:  2020-12-21

Review 2.  Neuroimmunology of Common Parasitic Infections in Africa.

Authors:  Richard Idro; Rodney Ogwang; Antonio Barragan; Joseph Valentino Raimondo; Willias Masocha
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

3.  Porcine model of neurocysticercosis by intracarotid injection of Taenia solium oncospheres: Dose assessment, infection outcomes and serological responses.

Authors:  Gianfranco Arroyo; Luz Toribio; Ana Vargas-Calla; Juan F Calcina; Edson Bernal; Nancy Chile; Miguel Zambrano; Luis A Gomez-Puerta; Juan Chacaltana; Miguel Marzal; Javier A Bustos; Manuela R Verastegui; Robert H Gilman; Seth E O'Neal; Armando E Gonzalez; Hector H Garcia
Journal:  PLoS Negl Trop Dis       Date:  2022-06-02

4.  In Vivo Treatment with the Combination of Nitazoxanide and Flubendazole Induces Gluconeogenesis and Protein Catabolism in Taenia crassiceps cysticerci.

Authors:  Nayana F Lima; Guaraciara A Picanço; Tatiane L Costa; Ruy de Souza Lino Junior; Marina C Vinaud
Journal:  Acta Parasitol       Date:  2020-08-05       Impact factor: 1.440

Review 5.  Neurocysticercosis and movement disorders: A literature review.

Authors:  Jamir Pitton Rissardo; Ana Letícia Fornari Caprara; Ícaro Durante
Journal:  Brain Circ       Date:  2020-12-29

6.  The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.

Authors:  Hugo Rolando Vaca; Ana María Celentano; María Agustina Toscanini; Tino Heimburg; Ehab Ghazy; Patrik Zeyen; Alexander-Thomas Hauser; Guilherme Oliveira; María Celina Elissondo; Manfred Jung; Wolfgang Sippl; Federico Camicia; Mara Cecilia Rosenzvit
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

7.  Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model.

Authors:  Priscilla Kolibea Mante; Nana Ofori Adomako; Paulina Antwi; Nana Kofi Kusi-Boadum
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-06-07

8.  Mechanisms of the host immune response and helminth-induced pathology during Trichobilharzia regenti (Schistosomatidae) neuroinvasion in mice.

Authors:  Tomáš Macháček; Roman Leontovyč; Barbora Šmídová; Martin Majer; Oldřich Vondráček; Iveta Vojtěchová; Tomáš Petrásek; Petr Horák
Journal:  PLoS Pathog       Date:  2022-02-04       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.